EILEEN CHEEVER: Open Payments
NPI 1205099785 · LEOMINSTER, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$147,614 in 325 payments from 14 companies in 2025. Trend: 2023 $71,645 · 2024 $110,059 · 2025 $147,614
Speaker / faculty: $100,571Travel & lodging: $16,400Consulting: $16,236Honoraria: $9,240Food & beverage: $5,163Education: $5
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 88 | $44,101 |
| Regeneron Healthcare Solutions, Inc. | 103 | $31,141 |
| GENZYME CORPORATION | 26 | $17,976 |
| Janssen Biotech, Inc. | 24 | $15,399 |
| ABBVIE INC. | 29 | $13,124 |
| Organon LLC | 17 | $10,403 |
| E.R. Squibb & Sons, L.L.C. | 14 | $6,643 |
| Arcutis Biotherapeutics, Inc. | 3 | $4,698 |
| Eli Lilly and Company | 10 | $3,768 |
| Novartis Pharmaceuticals Corporation | 1 | $125 |
Products named: DUPIXENT, EBGLYSS, TREMFYA, SKYRIZI, VTAMA, Sotyktu, Zoryve, RINVOQ.
Industry payments across MA — which companies pay providers there.
